Company Filing History:
Years Active: 2016-2019
Title: Mikhail Martchenko: Innovator in Pathogen Inhibition
Introduction
Mikhail Martchenko is a notable inventor based in Claremont, CA (US). He has made significant contributions to the field of pathogen inhibition, holding a total of 3 patents. His work focuses on developing compositions and methods to combat various pathogenic agents.
Latest Patents
Martchenko's latest patents include innovative approaches to inhibit multiple pathogenic agents using bithionol. This patent provides compositions and methods for treating, inhibiting, or preventing caspase-dependent pathogenic agents in a host cell or infected subject. The pathogenic agents targeted include ricin, anthrax toxin, Botulinum neurotoxin A, diphtheria toxin, exotoxin A, cholera toxin, Zika virus, and combinations thereof. Additionally, his work incorporates bithionol in combination with antibiotics for more effective clearance of pathogens and toxins. Another significant patent focuses on inhibiting bacterial and viral pathogens using Amodiaquine (AQ) or N-Desethy Amodiaquine (DEAQ). This patent outlines methods for treating, inhibiting, or preventing cathepsin B dependent pathogens and toxins, also incorporating AQ or DEAQ with antibiotics for enhanced pathogen clearance.
Career Highlights
Mikhail Martchenko is affiliated with the Keck Graduate Institute of Applied Life Sciences, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on public health and safety.
Collaborations
Martchenko collaborates with esteemed colleagues, including William Leonardi and Kevin Jee Kim, to further his research endeavors.
Conclusion
Mikhail Martchenko's contributions to the field of pathogen inhibition through his innovative patents highlight his commitment to advancing medical science. His work not only addresses critical health challenges but also showcases the importance of collaboration in research and development.